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The NEUROWEB project supports cerebrovascular researchers’ association studies, intended as the search
for statistical correlations between a feature (e.g., a genotype) and a phenotype. In this project the phe-
notype refers to the patients’ pathological state, and thus it is formulated on the basis of the clinical data
collected during the diagnostic activity. In order to enhance the statistical robustness of the association
inquiries, the project involves four European Union clinical institutions. Each institution provides its pro-
prietary repository, storing patients’ data. Although all sites comply with common diagnostic guidelines,
they also adopt speciﬁc protocols, resulting in partially discrepant repository contents. Therefore, in order
to effectively exploit NEUROWEB data for association studies, it is necessary to provide a framework for
the phenotype formulation, grounded on the clinical repository content which explicitly addresses the
inherent integration problem.
To that end, we developed an ontological model for cerebrovascular phenotypes, the NEUROWEB Refer-
ence Ontology, composed of three layers. The top-layer (Top Phenotypes) is an expert-based cerebrovascu-
lar disease taxonomy. The middle-layer deconstructs the Top Phenotypes into more elementary
phenotypes (Low Phenotypes) and general-use medical concepts such as anatomical parts and topological
concepts. The bottom-layer (Core Data Set, or CDS) comprises the clinical indicators required for cerebro-
vascular disorder diagnosis. Low Phenotypes are connected to the bottom-layer (CDS) by specifying what
combination of CDS values is required for their existence. Finally, CDS elements are mapped to the local
repositories of clinical data. The NEUROWEB system exploits the Reference Ontology to query the differ-
ent repositories and to retrieve patients characterized by a common phenotype.
 2009 Elsevier Inc. All rights reserved.1. Background
The NEUROWEB project aims to support association studies in
the ﬁeld of cerebrovascular disease, by providing a framework for
clinical data integration and exchange. In general, the purpose of
association studies is to ﬁnd statistical relationships between a
(set of) feature(s) and a phenotype, which is a composite observa-ll rights reserved.
ct NEUROWEB Grant 518513
.
.it, marcoxa@cs.nyu.edu (M.ble state of an individual organism. NEUROWEB phenotypes specif-
ically correspond to the pathological state of the patients,
formulated according to clinical data collected during the diagnos-
tic activity. In addition, the project is speciﬁcally committed,
although not restricted, to provide support for exploring geno-
type–phenotype relations [1,2].
In order to achieve statistical robustness in these studies, large
patient cohorts are required. To accomplish this goal, the NEURO-
WEB project involves four clinical sites from different EU-member
countries, which are recognized excellence centers in the ﬁeld of
cerebrovascular diseases, with a particular focus on ischemic
stroke. Although all sites comply with international guidelines,
they have developed speciﬁc competencies in different areas of
stroke diagnosis, treatment and stroke research (such as imaging,
2 This is a very active research area; see, for example [32]
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requirements, though with speciﬁc skills and research commit-
ments, is mirrored by the content of their clinical repositories,
which were independently developed to store the patients’ proﬁles
gathered during the diagnostic activity. The size of each data
repository varies from 500 to 1500 patient records.
The exploitation of NEUROWEB local repositories for associa-
tion studies presents two major modeling aspects (cf. [3–5]):
(1) developing an IT infrastructure enabling the access to differ-
ent technological platforms for data storage (inter-
operability);
(2) resolving the semantic misalignments among locally-deﬁned
clinical indicators, yet preserving the methodological coher-
ence and consistency of phenotype formulation.
Speciﬁcally, the misalignment among clinical indicators does
not rest on a purely linguistic or terminological basis, as displayed
by the following cases.
(1) The same type of exam can be performed using different
diagnostic methodologies or technology (e.g., CTA scan vs.
MRI scan), with different implications for diagnostic
reliability.
(2) Different ﬁndings can be derived from the raw results of the
same type of exam; as a consequence, the same clinical indi-
cator may have different values in different sites (e.g., Brachi-
ocephalic artery lesion, derived from CTA scan results).
(3) Different scale of granularity, intended as level of detail con-
cerning the patient’s state assessment (e.g., ICA–CCA Stenosis
Present/Absent vs. ICA–CCA Stenosis Left Present / Absent).
(4) Different criteria can be applied to assign a stroke classiﬁca-
tion label (e.g., Atherosclerotic Ischemic Stroke) by combining
different clinical indicators, or by setting different criteria
(e.g., ranges, thresholds, acceptable values, etc.) on the same
indicators.
Many state-of-the-art solutions for data integration (for health
care as well as other domains) revolve around the idea of database
schema matching, i.e., establishing relations between elements
from local databases [6,7]. Database schema matching can be sup-
ported by semantic models, specifying the meaning of concepts be-
hind database elements. Such models can range in complexity
from simple graphs to semantic networks and domain ontologies
[8,9].
An important distinction can be set between systems relying
on a single, global conceptual schema or local, independent con-
ceptual schemas. The two solutions have speciﬁc advantages and
disadvantages: the global schema solution requires a constant up-
date of the semantic model whenever local databases change,
whereas local schemas can be hard to reconcile unless they are
already based on shared concepts or terminologies. Of course,
there are already several systems exploiting terminological re-
sources, ‘‘semantic mediators” or ontological knowledge models
for data integration and retrieval; a few examples are [10–13].
Also, several Ontology-based (OB)-Systems supporting high-
throughput processing of biological and clinical data have ap-
peared [14–21].
These systems are traditionally aimed at gathering genotypic
information associated to patients [21] through the adoption of
bio-ontologies. The genotypic information gathered is then used
either to guide data selection and knowledge discovery processes
[18], or for biomedical data integration, extraction and mining
[14,17,20]. A uniﬁed panorama of available bio-ontologies is of-
fered by the National Center for Biomedical Ontology (NCBO) Bio-
portal [19].With respect to existing OB-Systems supporting phenotype–
genotype scientiﬁc inquiries, NEUROWEB primarily copes with
the representation of the clinical rather than biological knowledge
involved in association studies. Moreover, case-control studies
have to be exhibited [22] in order to strengthen an association
hypothesis between a given polymorphism and phenotypic pro-
ﬁles of cerebrovascular diseases [23,24]. Such investigation re-
quires both a robust clinical knowledge modeling (i.e., clinical
phenotype ontology) and the deﬁnition of ad hoc system modules
that guarantee the methodological coherence in data mapping,
data extraction and data collection (i.e., IT-facilities described in
the following sections). No state-of-the art systems nor state-of-
the-art ontologies on clinical phenotypes modeling (as discussed
in [25]) to support clinical based testings of hypothesized pheno-
type–genotype associations were available at the time the NEURO-
WEB project began, nor, to the best of our knowledge have been
developed in the meantime.
Given this background, the NEUROWEB project set forth to pro-
vide its own form of integration. In the case of NEUROWEB Project,
semantic reconciliation goes a step further than straightforward
database schema matching. In fact, the NEUROWEB system was
designed to offer clinicians, and also biologists, the capability of
performing collaborative research through access of a network of
data repositories. Each repository could be queried either using
uniﬁed, higher-level concepts referring to common-use cerebro-
vascular phenotypes, or using new, user-deﬁned phenotypes,
assembled from elementary phenotype units. To achieve this goal,
we developed an ontological model [26–30] for cerebrovascular
phenotypes – the NEUROWEB Reference Ontology – that accurately
captures the core diagnostic/classiﬁcatory knowledge of clinicians.
The development of the Reference Ontology required very inten-
sive knowledge acquisition and knowledge structuring activities,
leading to a progressive reﬁnement of the semantic model, as de-
scribed in Section 2. In the ﬁnal model, top-level diagnostic classes
are deconstructed into more elementary phenotypes and medical
concepts. Every phenotype is associated to the speciﬁc combina-
tion of clinical indicators required for its occurrence. The content
of local databases is mapped to the Reference Ontology locally;
the current version relies on direct mapping and simple rules,
but the future adoption of local ontologies, to capture local features
in a more expressive way, is supported as well. Speciﬁcally, map-
ping local database elements to the ontology elements enables
the reconciliation of granularity discrepancies between locally-de-
ﬁned clinical indicators that would be hard to manage using direct
mappings between such elements. The adoption of a Reference
Ontology grounded on expert knowledge grants the respect of
methodological consistency, which is an essential requirement
for association studies.
A major decision to be taken was to choose between the devel-
opment of a speciﬁc Reference Ontology and the adoption of an
existing one [31]. The second solution would apparently offer
superior advantages, by granting inter-operability with external
resources, and by facilitating the involvement of new partners in
case they are already complying with an existing ontology. How-
ever, there are crucial problems undermining this solution. Indeed,
no publicly-available medical ontology is committed to the repre-
sentation of clinical ﬁndings and phenotypes.2 The phenotype
ontologies developed within the biological community are oriented
to high-throughput genetic experiments in model organisms
[29,33,34], and hence are not suitable for clinical applications. From
a pragmatic perspective one may argue that even if an optimal solu-
tion is not available, the reuse of an existing general-purpose medi-
cal ontology may still offer signiﬁcant advantages. As a case in point,
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against it because of a number of actual shortcomings that would
be encountered by adopting it (see also [35–37]).
 Considering the stroke type taxonomy used by NEUROWEB
clinicians, most of the concepts are either missing from
SNOMED-CT, or they are formulated in an unsuitable way.
For instance, the deﬁnition of SNOMED-CT Atherosclerotic
Occlusive Disease clearly implies an atherosclerotic etiology,
but not the speciﬁc features of stroke, which are part of the
NEUROWEB Ischemic Stroke deﬁnition. In addition, several
clinical indicators required for stroke diagnosis and present in
NEUROWEB clinical repositories are missing from SNOMED-CT
(e.g., relevant scan lesion).
 SNOMED-CT offers qualitative scales for clinical ﬁndings but
does not provide quantitative criteria to assign them (e.g., no
stenosis percentage ranges are associated to the previous scale),
nor does it resolve inter-dependencies among different
indicators.
Similar shortcomings are displayed by other medical re-
sources, proving that these problems are not speciﬁc of
SNOMED-CT only. For instance, the Disease Ontology [38] is a
general-purpose classiﬁcation of pathologies, describing biologi-
cal-samples within genetic data banks (developed for the NUgene
project). The Disease Ontology includes concepts which have ter-
minological correspondence to NEUROWEB phenotypes and clin-
ical indicators (e.g., Stroke, Atherosclerosis, Subarachnoid
hemorrhage, Cerebral embolism, Cerebral thrombosis, Occlusion and
stenosis of carotid artery, etc.). However: (1) they do not follow
the taxonomy adopted by the cerebrovascular clinicians who
are part of the NEUROWEB network; (2) no criteria are provided
to assign them on the basis of clinical data; (3) the concepts are
organized by adopting only is-a, part-of, inverse-of, union-of and
disjoint-from relations, thus lacking any speciﬁcation of causality
or diagnostic evidence. As a whole, there is a wealth of knowl-
edge, relevant to the aims of the NEUROWEB system, which could
not be properly conveyed by this ontology. Consequently, it was
decided to develop a new Reference Ontology committed to accu-
rately represent the diagnostic knowledge of the NEUROWEB
community. Nonetheless, NEUROWEB concepts were mapped to
external terminologies to support keyword-based searches in
external resources. The value and validity of the diagnostic
knowledge encoded by the NEUROWEB Reference Ontology is
not restricted to the NEUROWEB Consortium, as the stroke type
taxonomy adopted largely follows the TOAST classiﬁcation guide-
line. This resource was developed by cerebrovascular experts, and
is regarded as a reliable standard by the international cerebrovas-
cular community [39–41].2. The Development of the NEUROWEB Reference Ontology
The development of the NEUROWEB Reference Ontology
proceeded iteratively over a number of phases. In the narrative
of Section 2.1, we identify three major phases where design
decisions where made and provide a rationale for the choices
made.2.1. Initial models
2.1.1. Basic level deﬁnition
The modeling activity started by identifying a minimal set of
clinical indicators (Core Data Set, in brief CDS), mapped to the
majority of the local repositories and of primary importance for
stroke diagnosis. In a sense, the CDS is the equivalent of one ofthe numerous minimal information speciﬁcations now coordinated,
e.g., in the MIBBI project [42]. The deﬁnition of the CDS was char-
acterized by close collaboration with clinicians, and several cycles
of reﬁnement at round table meetings.
The most straightforward solution for clinical data integration
consists in mapping the content of local repositories to the CDS.
In this scenario, the user formulates queries on the CDS indica-
tors, which are then translated on local databases. This solution
is problematic, as there are often granularity discrepancies be-
tween local indicators, preventing a direct mapping to CDS ele-
ments (e.g., scan lesion = yes vs. scan lesion side = LEFT). In
addition, some CDS indicators are not atomic, meaning that they
implicitly refer to other entities of the CDS. For instance, relevant
scan lesion does not refer to a single exam result; according to
diagnostic knowledge, a lesion is relevant only in the presence
of a co-axial scan lesion (i.e., the evidence of some brain tissue
damage) and stenosis (i.e., the evidence of a partial occlusion
in a brain-afferent artery). It follows that relevant scan lesion = yes
requires a set of constraints on several atomic entities of the
CDS, namely:
scan lesion = yes,
stenosis degree > 50%,
side of the scan lesion = RIGHT (LEFT), and
side of the stenosis = RIGHT (LEFT).
Stroke classiﬁcation labels (e.g., TOAST Atherosclerotic Ische-
mic Stroke Evident) are a speciﬁc type of non-atomic CDS indica-
tors. They characterize the patient’s state in a comprehensive
way, implicitly encompassing many other indicators. These
classiﬁcation labels could be used to directly retrieve patients
for association studies. However, since they were manually as-
signed by clinicians, errors and methodological inconsistencies
are possible. In particular, it is possible that different clinicians
or different sites used different criteria for their assignment.
For this reason, using the stroke classiﬁcation labels would be
a satisfactory solution under the mere perspective of inter-
operability, but methodological coherence and consistency,
which are crucial for rigorous association studies, may not be
ensured.
In conclusion, the CDS alone is insufﬁcient and a richer model is
required, utilizing the CDS as the groundwork.2.1.2. Two-layers solution
We next developed a model composed of two layers, where the
top-layer is a taxonomy of phenotypes (Top Phenotypes), each con-
nected to the CDS entities (the bottom-layer) via a deﬁnition for-
mula. The formula is structured as a conjunction/disjunction of
criteria on CDS indicators, expressed as equality/inequality bounds,
or quantitative ranges to be satisﬁed. For instance: (Blood pres-
sure > 50) AND (Anterior cerebral artery lesion = yes).
The model above was used for an extensive knowledge acquisi-
tion activity with clinicians. It offers the advantages of being sim-
ple to understand, and it includes entities already familiar to the
clinicians. Using the CDS entities to formulate Top Phenotypes also
provided valuable feedback for the reﬁnement of the content and
structure of the CDS.2.1.3. Three-layer solution
The major weakness of the two-layer model is the absence of
relations deconstructing the stroke types into more elementary
phenotypes and medical concepts of general use (e.g., co-occurring
pathologies such as diabetes and obesity, anatomical parts, topo-
logical concepts). This additional array of entities is necessary to
support important functionalities.
Reference Ontology
Top Phenotypes 
(stroke taxonomy) 
Low Phenotypes 
(building blocks) 
Local Clinical Repositories 
Core Data-Set 
(clinical indicators) 
NEUROWEB to Local Mapping 
Topology 
& 
Anatomy 
Phenotype 
Ontology 
Ischemic Stroke 
Indicator 
Value 
Mapping 
Rule 
Fig. 1. The diagram displays the overall architecture of the NEUROWEB Reference Ontology.
472 G. Colombo et al. / Journal of Biomedical Informatics 43 (2010) 469–484 Simplify the handling of the phenotype formulas; in fact, sub-
units of the full deﬁnition formula can be associated to certain
aspects of the pathological state, of general validity even in a dif-
ferent context than the stroke specialty.3
 Establish a mapping to medical ontologies and terminologies
(e.g., SNOMED-CT, MeSH [43,44]), in order to support document
retrieval, and other searches on resources outside the NEURO-
WEB consortium.
 Support the integration of bioinformatics resources for geno-
type–phenotype association (e.g., the Human Gene Mutation
Database – HGMD [45,46]) and gene function (most notably
from the Gene Ontology [47]).
These problems can be overcome by adopting an ontological
framework for phenotype formulation and introducing an addi-
tional layer (Low Phenotypes) to deconstruct the Top Phenotypes
into more elementary concepts.
Henceforth, the resulting model is composed of three layers,
and it will be fully described in Section 2.2.
2.2. The ﬁnal ontology architecture
The NEUROWEB Reference Ontology is composed of three lay-
ers (Fig. 1).
 Top Phenotypes: taxonomy of stroke types.
 Low Phenotypes: anatomical parts, topological relations, diseases
and other phenotypes.
 Core Data Set (CDS): uniﬁed clinical indicators.
The Top and Low Phenotype are grouped into the Phenotype
Ontology, which, alongside the CDS, is part of what we refer to as
the NEUROWEB Reference Ontology. The CDS (bottom level) is the
set of minimal-granularity clinical indicators required for stroke
diagnosis. The Phenotype Ontology is composed of Top Phenotype
and Low Phenotype layers. The Top Phenotype layer is a taxonomy3 For instance, the Top Phenotype Atherosclerothic Ischemic Stroke can be decom-
posed into two parts: the Ischemic Stroke (a cerebrovascular accident), and its durative
etiological factor Atherosclerosis (a vessel disease). Identifying these two parts is useful,
as the Ischemic Stroke unit is also a part of Cardioembolic Ischemic Stroke, another Top
Phenotype.of stroke types, connected to the Low Phenotype layer by relations
such as causality and existence of diagnostic evidence; the decon-
struction of Top Phenotypes into low Phenotypes provides an ex-
plicit model for the inherent classiﬁcation criteria underlying the
Top Phenotype taxonomy. Finally, the Low Phenotypes are con-
nected to the CDS entities and the corresponding combination of
values required for the phenotype to occur.
Mapping from NEUROWEB Reference Ontology elements to lo-
cal repositories occurs primarily at the CDS level. However, map-
ping to Low Phenotypes is also possible; this solution ensures the
handling of the aforementioned granularity discrepancies between
local repositories (cf. Section 2.1), as the phenotype ontology pro-
vides progressively more general concepts than the CDS. For more
details on the mapping solution, please refer to Section 3.2.2.2.1. The Core Data Set
In the ﬁnal, three-layer model, the CDS was restricted to mini-
mal-granularity clinical indicators. In fact, non-atomic concepts
are handled within the Phenotype Ontology (e.g., stroke classiﬁca-
tions are represented by Top Phenotypes). For this reason, mapping
to local repositories is not restricted to the CDS layer.
The CDS entities are organized into categories and sub-catego-
ries, according to the different types of examinations (see Fig. 2).
In general, the values of CDS entities can be quantitative (e.g.,
Age, Hemoglobin on admission g/dL), Boolean (e.g., Current use of alpha
blockers: yes, no), or categorical (e.g., Cognitive Function: normal, mildly
impaired, confused; Gender: male, female).2.2.2. The Phenotype Ontology
The upper-layer of the Phenotype Ontology is populated by the
Top Phenotypes. These entities represent the main classes of path-
ological states typically diagnosed by clinicians. They are inter-re-
lated by is-a relations, thus forming a taxonomy of stroke types.
The root of the taxonomy is Ischemic Stroke, whose children are
Atherosclerotic Stroke, Cardioembolic Stroke and Lacunar Stroke; these
stroke types constitute the three main etiological groups, as they
are identiﬁed in the TOAST classiﬁcation. Each of them is then di-
vided into Evident, Probable and Possible. Deeper levels of phenotype
speciﬁcation (e.g., according the anatomical location of the vascu-
lar lesion) lead to the addition of children to these stroke subtypes.
Age
Cholesterol on Admission
Facial Palsy
ECG (Electrocardiogram) Rhythm on Admission
Routine Blood Tests Hemoglobin on Admission
negonirbiFseidutSnoitalugaoC
Follow-up Information Month 1
Follow-up Information Month 3
Follow-up Information Month 6
Follow-up Information Month 12
Medication at Follow-up Month 1
Medication at Follow-up Month 3
Medication at Follow-up Month 6
Medication at Follow-up Month 12
TOAST - Classical
TOAST - Extended
ICD-9CM
OCSP
Carotid Bifurcation Stenosis
Main Categories
Gender
Location of the Lesion
Paroxysmal Atrial Fibrillation 
Personal Identifying Data 
Brain Imaging Studies
Clinical Data 
Sub-Categories
Heart Studies
Transesophageal-echocardiogram
Example Entities
CT (Computed Tomography)
MRI (Magnetic Resonance Imaging)
Internal Carotid Artery Stenosis
Holter 
Right-left Shunt
Vessel Studies
CTA (Computed Tomography Angiography)
MRA (Magnetic Resonance Angiography)
DSA (Digital Subtraction Angiography)
Duplex
Follow-up Information Cognitive Function
Laboratory Studies
Classification
Medication at Follow-up Current Use of Alpha-blockers
Fig. 2. The table displays the categories and sub-categories used to organize the CDS entities. An example of CDS entity is provided for each partition. The classiﬁcation layer
is shaded, as these indicators are conveyed by Top Phenotypes, and were part of the CDS only in the initial models.
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Low Phenotypes,we followed the TOAST classiﬁcation criteria.
 Etiology (Atherosclerotic, Cardioembolic, Lacunar Stroke).
 Conﬁdence of the etiological assessment (Evident, Probable, Pos-
sible), depending on the strength of the diagnostic evidence for
the most-probable etiology.
In addition, anatomy (i.e., the location of the lesion) is not used
by the TOAST, but could be suitably used to extend it, and is con-
sistently used in the different clinical communities. These criteria
are explicitly recognized by the clinicians, and are generally used
in clinical medicine.
It is also important to consider that diagnostic activity is always
characterized by the acquisition of diagnostic evidences, enabling
the reconstruction of the undergoing patho-physiological processes
and structures, even if they are not directly observed. In the speciﬁc
case of ischemic stroke, there is a consistent partition between the
evidences for the ischemic damage (typically brain imaging display-
ing the damaged tissue, and the cognitive/motor impairment of the
patient) and the evidences for the cause of the occlusion causing
ischemia; the latter is usually a persistent or progressive state of
thepatient’s organism, such asAtherosclerosis, whereas the latter oc-
curs after a chain of point-events (i.e., with a very compact time-
span) eventually leading to a brain lesion (a trauma).
From a biological standpoint, however, it is important to repre-
sent not only the diagnostic evidences, but also the patho-physio-
logical processes inferred. In our modeling case, ischemic stroke is
caused by the rupture of an atherosclerotic plaque, triggering the
coagulation cascade, the release of a clot particle into the blood-
stream (embolization) and the obstruction of a brain artery, even-tually resulting in a brain lesion in the region deprived of the blood
supply. These processes can be captured at the biomolecular level
and represented in the ontology.
Reﬂecting the above mentioned criteria, the Top Phenotypes are
ﬁrst decomposed into Low Phenotypes (see Fig. 3) according to eti-
ology. We used two different causal relations:
 Has-Cause-Durative,
 Has-Cause-PointEvent.
Has-Cause-Durative connects a Top Phenotype to its Durative Etio-
logical Background (e.g., Atherosclerotic Disease), representing the
long-term pathology responsible for the generation of the ischemic
event. Has-Cause-PointEvent connects a Top Phenotype to its Trau-
matic Point Event, representing the cerebrovascular accident that
occurred in the patient. As far as the current version of the ontol-
ogy is concerned, this will be always IschemicEvent or any of its
speciﬁcations. However, cerebrovascular accidents other than
Ischemic Stroke can be represented as well (e.g., Hemorrhagic
Stroke).
This ﬁrst group of Low Phenotypes reﬂects patho-physiological
processes. The underlying biomolecular processes are connected
via the Involves relation. For more details on how biomolecular pro-
cesses are exploited by the system, please refer to Section 2.4.1.
Both Durative Etiological Background and Traumatic Point Event are
then connected to their diagnostic evidences (Durative or Point-
event, respectively), via the Has-Diagnostic-Evidence relation. Diag-
nostic evidences can be decomposed into more elementary diag-
nostic evidences using the same relation.
An additional dimension to be taken into account is the ana-
tomical location implied by the phenotype. Anatomical parts cannot
Fig. 3. The diagram displays the main types of entities and relations composing the NEUROWEB Reference Ontology. The three layers of the Reference Ontology (Top
Phenotypes, Low Phenotypes, CDS) correspond to the large shaded boxes in the background on the right side. Additional entity types are displayed on the left side. Colored
arrows represent relations. The graphical pattern A ! B1 ! B2 represents the DL construct: A  $relationX.(B1 u $relationY.B2).
Table 1
Description Logic code for the fragment of the NEUROWEB Reference Ontology
Atherosclerotic Ischemic Stroke Evident (AISE).
AISE  (1)
$hasCausePointEvent.IschemicEvent
u$ hasCauseDurative.(AtheroscleroticDisease
u$ hasDiagnosticEvidence.SevereStenosis)
IschemicEvent $ hasDiagnosticEvidence.RelevantLesion (2)
RelevantLesion  (3)
$ hasDiagnosticEvidence.LeftRelevantLesion
t$ hasDiagnosticEvidence.RightRelevantLesion
LeftRelevantLesion 
$ hasDiagnosticEvidence.((ModerateLesion t SevereLesion) u$
hasSide.Right)
u$ hasDiagnosticEvidence.(SevereStenosis u$ hasSide. Right)
ModerateLesion  (5)
Lesion u$ byMeansOf(CT-From2.5to5CentimetersLesion
t MRI-From2.5to5CentimetersLesion
t PET-From2.5to5CentimetersLesion)
CT-From2.5to5CentimetersLesion  CT u$ hasValue. 2.5-5centimeters (6)
MRI-From2.5to5CentimetersLesion MRI u$ hasValue. 2.5-5centimeters (7)
PET-From2.5to5CentimetersLesion  PET u$ hasValue. 2.5-5centimeters (8)
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rather physical entities bearing observable properties [29–31,33].
For this reason, we introduced new types of entities, Anatomical
Parts and Topological Concepts. Diagnostic evidences are connected
to Topological Concepts via the Has-Side relation, and to Anatomical
Parts via the Has-Location relation.
Low Phenotypes of type Diagnostic Evidence are ﬁnally decon-
structed into the exams required for their assessment. The Has-Va-
lue relation allows for the formulation of validity ranges that must
be satisﬁed by a CDS indicator, in order to elicit the occurrence of a
certain phenotype; the resulting construct is connected to the per-
tinent Low Phenotype through the relation By-Means-Of.
As an example of integration feasibility, the Phenotype Ontol-
ogy can be effectively mapped to other medical ontologies, in order
to support queries on external resources. At the present stage of
model development we provide the mapping between SNOMED-
CT terms and Reference Ontology entities, belonging to the Low
Phenotypes and the Anatomical Parts modules. The mapping can-
not be systematically provided for the Top Phenotypes and CDS
entities, as SNOMED-CT does not offer a satisfactory coverage, for
the reasons already explained in the Section 1.2.3. An example of phenotype formulation
As an example, let us have a look at the ontological deﬁnition
for the Top Phenotype Atherosclerotic Ischemic Stroke Evident (AISE);
see Table 1 and Fig. 4.
The ﬁrst axiom states (a) the existence of a relation from Athero-
sclerotic Ischemic Stroke Evident (AISE) to the Low Phenotype Ischemic
Event via the Has-Cause-PointEvent relation, and (b) the existence of
a relation from AISE to the Low Phenotype Atherosclerotic Disease via
the Has-Cause-Durative relation. As an additional requirement, Ath-
erosclerotic Disease must have Severe Stenosis as diagnostic evidence
– this is a speciﬁc requirement of Atherosclerotic Ischemic Stroke
when it is Evident. According to the second axiom, Ischemic Event re-
quires the presence of the diagnostic evidence Relevant Lesion; Ath-
erosclerotic Disease is not further decomposed just for the sake of
brevity. Relevant Lesion is further decomposed into Left and Right
Relevant Lesion, which consist of a Moderate or Severe Lesion con-nected to the topological indication of the side via the Has-Side rela-
tion. Moderate and Severe Lesion are eventually decomposed into
CDS elements and appropriate diagnostic values by the By-Means-
Of and Has-Value relations.2.4. Extensions of the NEUROWEB Reference Ontology
In the following we will brieﬂy discuss some extensions of the
NEUROWEB Reference Ontology under development: a terminolog-
ical extension to support text-search tools, a more sophisticated
treatment of the temporal dimension, and in more details the addi-
tion of a layer for the treatment of biomolecular processes.
One of the primary aims of the NEUROWEB Reference Ontology
is also to support the retrieval of patients characterized by a certain
phenotype. Nonetheless, such an semantically articulate model can
be usefully exploited also for text-mining purposes, thus support-
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Fig. 4. A visual diagram for the AISE DL formulation. Big boxes represent entities, arrows represent relations. Small gray boxes (transitions) are used to convey AND/OR logical
connections: AND corresponds to relations using the same transition, OR corresponds to relation using independent transitions.
G. Colombo et al. / Journal of Biomedical Informatics 43 (2010) 469–484 475ing the NEUROWEB in literature searches. To effectively support
the processing of texts, an ontology needs to be extended with a
terminological basis, i.e., the set of written expressions corre-
sponding to the ontology-encoded concepts [48]. A practicable
solution would be to link each phenotype concept to the corre-
sponding terms from publicly available terminological resources
(e.g., SNOMED-CT, MeSH, UMLS [49], ICD-9CM [50], ICD-10 [51]),
as was exempliﬁed in Section 2.2 for SNOMED-CT. Speciﬁcally,
the mapping to MeSH would be very effective in supporting Med-
line searches, as Medline is already indexed by MeSH terms. A case
could also be made to incorporate synonym searches over Word-
Net [52], although such searches would mostly yield uncontestual-
ized (in the biomedical sense) results. The terminological
extension of the Reference Ontology is currently under way, and
can be already used in its prototype stage.
The formal representation and the computational treatment of
the time dimension is a crucial topic for the data management sys-
tems [53] and the ontological knowledge representation area [54],
as well as for the biomedical support systems [55] and the devel-
oping area of biomedical ontologies [56,57].
According to [55] two main research directions drive the tem-
poral dimension issues within the biomedical and clinical informa-
tion system development: (1) temporal reasoning, in order tosupport inferential tasks, such as therapy planning and execution;
(2) temporal data maintenance topics, pertaining to the storage
and retrieval of clinical data having heterogeneous temporal
dimensions.
As far as the representation and reasoning issues are con-
cerned, the temporal dimension introduced by the diagnostic
activity – i.e., modeling the temporal order of the diagnostic
examinations, and the process of progressive hypothesis reﬁne-
ment – will not be addressed, as it would be out of the NEU-
ROWEB scope (that is, supporting association studies via
patients clustering). On the contrary, the temporal dimension
relevant to the NEUROWEB system concerns the formulation
of phenotype on the basis of dynamic patterns, i.e., the varying
behavior of clinical indicators over time. For instance, it could
be valuable to deﬁne improving or worsening conditions. Such
a modeling effort would require, on one hand, a systematic
treatment of repeated clinical examinations over time; on the
other hand, it would require an additional knowledge acquisi-
tion activity, in order to identify the criteria implicitly applied
by the experts when they recognize different classes of dynamic
patterns. Finally, the knowledge representation formalism could
reasonably be the one proposed in [54], or an adaptation of the
same.
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The NEUROWEB consortium is committed to integrate clinical
and genetic databases of the participating centres, referring to pa-
tients affected by cerebrovascular diseases that were studied with
high-throughput Single Nucleotide Polymorphism (SNP) [58,59] ge-
netic proﬁling. The data will be analyzed to identify statistically sig-
niﬁcant genotype–phenotype associations, fostering the discovery
of new diagnostic markers, disease genes and potentially therapeu-
tic targets. Due to co-inheritance patterns [58], the analysis of SNP
data typically poses a genomic mapping problem: given a certain
polymorphism, which is signiﬁcantly associated to the phenotype
of interest, it is often hard to assess what gene mutation is actually
responsible for the observed phenotype. One of the heuristics that
can be used to address this problem is to combine the newer whole
genome approachwith the older candidate gene approach [2], select-
ing for genes characterized by functions compatible with the ob-
served phenotype (e.g., cholesterol homeostasis in Atherosclerotic
Ischemic Stroke) [60]. The NEUROWEB Reference Ontology was ex-
tended to biomolecular entities in order to support this goal. In addi-
tion, to provide mappings to external resources, the ontology
includes Has-Reference relations connecting NEUROWEB processes
to gene functions from Gene Ontology (GO), and pathways from re-
sources suchasKEGG[61–63].Here followsaqualitativedescription
of how the NEUROWEB system supports polymorphism mapping.
The input consists of single SNP-phenotype associations.
 The SNP (identiﬁed by the NCBI dbSNP ID [59]) is mapped to its
genetic locus.
 The NEUROWEB Genomic Engine retrieves all the genes map-
ping to the locus; the Gene Ontology (GO) functional annotation
is retrieved for those genes.
 If any of the GO annotations are mapped to the NEUROWEB bio-
molecular processes, the ontology is navigated to identify one
(or more) connections to Low Phenotypes via the Involved-In
relation.
 The ontology is further navigated to search for connections
between the previously identiﬁed Low Phenotypes and the phe-
notype of interest (i.e., the one associated to the polymorphism).
 The system outputs the genes and the relative biomolecular pro-
cesses that are associated to a valid path. Output genes repre-
sent good candidates for the reﬁnement of the genotype–
phenotype association. The corresponding output biomolecular
processes offer a plausible functional explanation of the geno-
type–phenotype association.4
The implementation of this functionality in the NEUROWEB sys-
tem is currently under completion.
The biomolecular extension of the NEUROWEB Ontology can be
further exploited for the integration of NEUROWEB genotype–phe-
notype associations with data from publicly available resources
(e.g., the NIH Genetic Association Database [64]). This functionality
is currently under study; so far we have identiﬁed two major dis-
crepancies to be addressed.
 Use of different criteria to identify phenotypes and diseases.
 Phenotypes can be referred to different levels of biological
organization.4 For instance, let’s consider the association between a given SNP and the Top
Phenotype Atherosclerotic Ischemic Stroke Evident. The SNP is mapped onto an LDL
Receptor gene, annotated for Cholesterol Homeostasis according to Gene Ontology. GO
Cholesterol Homeostasis is connected to NEUROWEB Cholesterol Metabolism and Homeo-
stasis, and this process is connected to the Low Phenotype Atherosclerotic Disease, which
is connected to Atherosclerotic Ischemic Stroke Evident via Has-Cause-Durative. It is thus
possible to establish a valid path from Atherosclerotic Ischemic Stroke (and all its
offspring) to the SNP of interest, by traversing Atherosclerotic Disease and Cholesterol
Metabolism and Homeostasis.The ﬁrst problem occurs because, to the best of our knowledge,
there is no common ontology for clinical phenotypes working as a
common exchange language, and because different communities of
clinical expert may have speciﬁc needs. Thanks to the decomposi-
tion of the Top Phenotypes into the more general Low Phenotypes,
the NEUROWEB Reference Ontology is already structured to mini-
mize this problem. The second problem typically occurs when phe-
notype annotation refers to cellular and molecular processes or
components, whereas clinical phenotypes are most often referred
to the organ or system level.5 A complete solution of this problem
would require a systematic ontology of biological functions and
parts, spanning all the organization levels, from molecules to organs
and systems. Yet, a more limited yet satisfactory solution can be
achieved relating biomolecular processes to Low Phenotypes. Estab-
lishing such relations amounts to deﬁning the molecular mecha-
nisms of pathological manifestations (e.g., atherosclerosis, atrial
ﬁbrillation, etc.).3. Methods
3.1. Description Logic Implementation of the NEUROWEB Reference
Ontology
Description logics [65–67] are a family of logic-based knowl-
edge representation formalisms designed to represent and reason
about the knowledge of an application domain in a structured
and well-understood way. The basic notions in description logics
are atomic concepts and atomic roles (unary and binary predicates
in the terminology of ﬁrst order language, respectively). In order to
distinguish the function of each concept in the relation (repre-
sented by a role), the individual object that corresponds to the sec-
ond argument of the role, viewed as a binary predicate, is called
role ﬁller. For instance, hasPart.Wheel is an expression which de-
scribes properties of cars having wheels, in which the individual
objects belonging to the concept Wheel are ﬁllers of the role has-
Part. A speciﬁc description logic is mainly characterized by the con-
structors it provides to form complex concepts and roles from the
atomic ones. The language we used to formalize the ontological
clinical knowledge is SHOIN [65], which is an extension of the basic
description logic. In order to develop the Reference Ontology com-
putational model we have adopted the OWL DL version [68]. The
editor adopted for the OWL ﬁles generation is Protégé, a well
known tool developed and distributed by the Stanford University,
where the Reference Ontology concepts are represented as T-
Box (Terminological Box) entities.3.2. Exploiting the Reference Ontology for clinical queries
The NEUROWEB phenotypes are deﬁned in the Phenotype
Ontology as axioms that cannot be directly exploited to query
the local repositories, which are typically implemented with rela-
tional databases. To retrieve patient clusters on a phenotypic basis,
such high-level deﬁnitions need to be typically translated and
mapped into CDS entities and then into local database queries.
Moreover, since a local database may include only some of the
indicators represented by the CDS and possibly other elements,
the actual mapping may occur at different level of the Reference
Ontology. For example, a speciﬁc local database may include infor-
mation about a given phenotype (e.g., presence or absence of ste-5 E.g., HGMD phenotype Apolipoprotein A1 deﬁciency is related to an increased
susceptibility to thrombogenesis and embolization in presence of ulcerated athero-
sclerotic plaques, and thus should be related to the NEUROWEB Atherosclerotic Ischemic
Stroke.
Fig. 5. User interface of the Ontology Mapper tool for a ﬂat local database table. The user can select one or more local database ﬁelds (upper right) and assign them to a CDS
label or a phenotype (upper left). The tool generates the syntax for the mapping to be saved as an SQL view.
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WEB phenotype.
To deﬁne NEUROWEB-to-Local (N2L) mapping, local medical
experts familiar with the actual meaning, and – possibly – coding
of the local repository logical structure, are requested to map the
local repository elements to the Reference Ontology elements. In
order to facilitate this task, a graphical interactive tool, named
Ontology Mapper, has been developed as a Protégé plug-in. In most
cases the mapping may occur at the CDS level since the CDS struc-
ture should be quite similar to the one of the clinical repositories.
In some cases the mapping could be reduced to a linguistic trans-
lation of terms in the CDS into the local terminology, in other cases,
several local data ﬁelds may be used to construct a single CDS ele-
ment. However, to host new clinical partners it might be necessary
to map the Reference Ontology concepts or even to develop local
ontologies to express a more sophisticated relationship and exploit
the full range of the NEUROWEB solution (see Fig. 5).
The resulting high-level and CDS-level mappings are stored the
same way at clinical servers as database views in our prototype
implementation (cf., ‘‘Mapping to local entities” in Fig. 8). The
CDS labels and phenotypes that appear in these views are called
‘‘supported”, while others are ‘‘unsupported” by the clinical
partner.
The clinical sites periodically communicate the list of their sup-
ported CDS labels and phenotypes to the center for storage and use
when designing queries (cfr., ‘‘Mapping to supported entities” in
Fig. 8).
The support for phenotype-level mappings is useful to avoid
‘‘semantic gaps”, i.e., loss of information, in user queries. Such gaps
occur when querying for a phenotype whose CDS constituents can-
not be mapped to a local repository due to granularity discrepan-
cies. Mapping at the phenotype level increases the ﬂexibility of
the system. However, the user is given the opportunity to set con-straints on such ﬂexibility. To that end, we use a system of weights
and thresholds: the user can assign weights to speciﬁc components
of the query (e.g., certain CDS elements); then each record re-
trieved from each data source is scored, by summing the weights
of the supported ﬁelds. If this score does not satisfy a user-deﬁned
threshold, that record will not be output to the user (see Fig. 6).
The process of generating queries to access a local repository re-
quires two tasks: (1) the elements of the local repository need to be
mapped into the ones in the Reference Ontology and the CDS, and
(2) the NEUROWEB phenotypes need to be transformed in queries
in terms of the reference ontology elements that map to the local
repository.
To perform the two tasks, we have developed two components
that are part of the NEUROWEB architecture as illustrated in Fig. 8.
(1) The Phenotype Converter that relies on the mapping informa-
tion provided by every participating repository to generate tailored
SQL queries in the NEUROWEB terminology. (2) The NEUROWEB-
to-Local (N2L) Mapper that exploits the mapping information to
generate the actual queries that will be used to access the local
database.
The Phenotype Converter has been implemented as a Java cen-
tralized component to ensure the logic consistency over the set of
performed queries, exploiting the Jena programming interface [69]
to navigate the ontology and extract class names and axioms. In
practice, every request is decomposed in the same way according
to the current deﬁnitions included in the Reference Ontology;
whenever they change only the centralized component needs to
be changed without notifying the involved sites. This solution im-
proves the awareness of the users that can be immediately notiﬁed
about who is going to answer a speciﬁc query and how.
The conversion process essentially navigates the references
from the top level phenotype axioms to low phenotypes, and ﬁnal-
ly to conditions on CDS elements, which are the leaf nodes of the
Fig. 6. Two example mappings to local data ﬁelds in the PL-SQL language (simpliﬁed versions of the originals). The ﬁrst mapping maps the local ﬁeld stroke.ctl to the
phenotype Presence_Of_Carotid_Stenosis if the ﬁeld contains the speciﬁed string. The second mapping creates the CDS label F.01.04.09.01.00.00 (code for Documented
recurrent stroke/TIA) using the local ﬁelds stroke.nihss6ho and stroke.nihss12ho.
Fig. 7. A visual diagram for the Presence of Carotid Occlusion as represented in the
Reference Ontology. Big boxes represent entities, arrows represent relations. Small
gray boxes (transitions) are used to convey AND/OR logical connections: AND
corresponds to relations using the same transition, OR corresponds to relation using
independent transitions.
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by-means-of relations are used. By combining the simple conditions
with the operators and quantiﬁers of the axiom, the top-level phe-
notype can be represented as a nested AND/OR expression includ-
ing the elements that are supported at a speciﬁc site.
However, before generating a CDS-level query, the Phenotype
Converter always checks if a phenotype-level mapping is available
for all or a part of a phenotype tree. If yes, the high-level mapping
is used in preference to the CDS-level mapping. This means that
the name of the phenotype will appear in the SQL query instead
of its CDS-level representation.
As an example, consider the fragment of the NEUROWEB Ontol-
ogy in Fig. 7; it represents a simpliﬁed version of Presence of Carotid
Stenosis concept as deﬁned by the NEUROWEB clinicians. In a pa-
tient the presence of a stenosis in the carotid artery may be diag-
nosed, if there is evidence of it in the segment called Internal/
Common Carotid Artery (ICA–CCA) or in the Origin of the Common
Carotid Artery. The ICA–CCA Stenosis can be diagnosed if there is
evidence of it in the right or in the left Internal/Common Carotid
Artery and in particular if there is an evidence of a severe stenosis
or a complete occlusion of the vessel.
One of the two branches reaching the last level of the ontology
states that the occlusion must be diagnosed by means of the CDS
indicator Duplex Carotid Degree Of Stenosis in Left CCA–ICA, and that
this indicator must have value (Occlusion). For every clinical site,
the mapping can be done at the best ﬁtting level: for example if
the clinical database ‘‘A” includes information only about the pres-
ence of a carotid stenosis in the patient, but without details on its
position, the mapping can be done only at the phenotype level, but
not at the CDS level. Thanks to the phenotype-level mapping, a
generic query that asks for patients with carotid stenosis will re-
ceive reliable answers. For more speciﬁc queries, for example select
all patients with a stenosis in the Internal Carotid Artery, the database
‘‘A” cannot provide answers due to a lack of information.
Fig. 8. The ﬁgure displays the information ﬂow of a clinical query in the NEUROWEB system. The software modules are displayed as solid boxes, whereas the data items are
displayed as cylinders. The dashed boxes group the components of a local site (only two sites were depicted for reasons of compactness). Thick arrows identify the
information ﬂow elicited by each user’s query.
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depending on the level of detail at which it is mapped. The Pheno-
type Converter performs this task. In the previous example, a query
select all patients with presence of carotid stenosis = Yeswill easily re-
ceive answers from the database ‘‘A”, but it must also receive an-
swers from a database ‘‘B” that supports mapping at the CDS
level. The Phenotype Converter translates the previous query into
select all patients with Duplex Carotid Degree Of Stenosis in Left
CCA–ICA = Occlusion OR Duplex Carotid Degree Of Stenosis in Left
CCA–ICA = Severe OR Duplex Carotid Degree Of Stenosis in Right
CCA–ICA = Severe OR . . . OR Duplex Carotid Degree Of Stenosis in Ori-
gin Common = Severe’, by following the Ontology axioms that state
how each concept is deﬁned in terms of CDS elements.
Of course, a database ‘‘C” can be mapped at any intermediate le-
vel. For example, if the distinction between the ICA–CCA and the
Origin Common Carotid Artery were present in database ‘‘C”, the
mapping would occur at that level, and the query would be trans-
lated in select all patients with ICA–CCA Stenosis = Yes OR Origin Com-
mon Carotid Artery Stenosis = Yes.
The NEUROWEB system exploits well-established Web ser-
vices technology to decouple the central components from the lo-
cal sites in order to facilitate access by new clinical partners.
Although each partner is free to chose the preferred technology
to implement the local components, we have developed and
made available a reference implementation to deliver a sample
solution that exploits the popular open-source technologies
Glassﬁsh for the communication tasks [70] and Postgres [71] for
implementing the database view.
Glassﬁsh safely manages call wrappings to expose the local
interface as a WSDL document. The Clinical Query Application runs
as a web application on the Glassﬁsh server, processes the incom-
ing web service call, translates it into a SQL query, runs the query
on the database view, wraps and returns the resulting record set.4. Conclusions
The purpose of the NEUROWEB Reference Ontology is to sup-
port the retrieval of patient clusters in a rich semantic context,
coupled with strict requirements on the clarity and coherence of
clustering criteria. In fact, the criteria adopted to categorize pa-
tients in computer-unaided practice are deeply rooted in diagnos-
tic knowledge of the cerebrovascular experts. In addition, the
speciﬁc commitment to association studies is particularly demand-
ing from a methodological standpoint: on one hand, it is effective
to provide the different researchers with a set of common and ex-
plicit clustering criteria, endued with a shared semantic; on the
other hand, it is necessary to grant coherence and consistency
when different repositories are integrated into a uniﬁed, virtual
data warehouse. The tremendous importance of such issues is
the rationale driving the cerebrovascular community to establish
standards for stroke classiﬁcation, such as the TOAST [39–41]; in
particular, the growing amount of available data requires the adop-
tion of computer-aided practices, and thus formal representation
of classiﬁcation systems.
The speciﬁc advantages provided by an ontological modeling
approach with respect to the issues discussed are clear. On one
hand, the explicit representation of classiﬁcation criteria, as pro-
vided by the layer of the Low Phenotypes, enables to analytically
express the meaning of the groupings organized in the Top Pheno-
type layer. On the other hand, the mapping to the local clinical
repositories, mediated by the Core Data Set layer, enables an auto-
mated retrieval of patient clusters driven by the previously deﬁned
criteria, which spares the researcher from tedious and time-con-
suming query formulation activities, though preserving methodo-
logical coherence. Considering this latter issue, the main problem
is that different repositories contain classiﬁcation data, but it is
not granted that they were assigned applying coherent criteria.
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work provides a formalization of concepts explicitly or implicitly
encoded in the TOAST system, a scope not addressed by the avail-
able medical ontologies. According to this perspective, the NEURO-
WEB modeling effort, in spite of its prototypical nature, covers an
unchallenged area of medical knowledge representation, which
can be reasonably deemed to elicit the interest of the broader cere-
brovascular community.
An even greater challenge is posed by the analysis and valida-
tion of genotype–phenotype associations, which will be gener-
ated by high-throughput genotyping campaigns on NEUROWEB
patients. Nevertheless, the present structure adopted for the
ontological model proved to be already adequate for the exten-
sion to the biomolecular domain, providing an effective ground-
work to establish relations between cerebrovascular pathologies
and their underlying molecular mechanisms. As a whole, the
Low Phenotype layer, by analytically deconstructing the stroke
types into general concepts of the cerebrovascular domain, pro-
vides an effective groundwork both for (a) the phenotype redef-
inition, and (b) the representation of relations betweenFig. A.1. Speciﬁcation
Fig. A.2. The Phenotypecerebrovascular pathologies and their underlying molecular
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Table A.1
Example A. The query compiled for Clinic A (with full CDS-level mapping).
SELECT
//patient ID, selected automatically
‘‘A.01.01.01.00.00.00”,
//the CDS codes for the 5 elements speciﬁed in step 5
‘‘A.01.01.02.00.00.00”,
‘‘A.01.02.01.01.00.00”,
‘‘A.01.02.09.02.01.00”,
‘‘D.01.01.01.00.00.00”,
‘‘A.01.01.07.00.00.00”
FROM <local database view name at clinic A>
WHERE
‘‘A.01.01.01.03.00.00” = 1 //meaning gender = female
AND ( //deﬁnition of Atherosclerotic_Ischemic_Stroke
( //deﬁnition of Ischemic_Stroke,
//involving 11 CDS-level constraints, NOT DETAILED HERE
. . .
)
AND (
//deﬁnition of Atherosclerotic_Disease,
//involving 5 CDS-level constraints
‘‘A.01.02.02.10.01.00” = 2 //myocardial infarction
‘‘OR A.01.02.02.11.01.00” = 2 //angina pectoris
‘‘OR A.01.02.02.09.01.00” = 2 //family stroke/TIA
‘‘OR A.01.02.02.05.01.00” = 2 //arterial hypertension
‘‘OR A.01.02.02.07.01.00” = 2 //hypercholesterolemia
)
)
Table A.2
Example B. The query compiled for Clinic B (with a phenotype-level mapping).
SELECT
//patient ID, selected automatically
‘‘A.01.01.01.00.00.00”,
//the CDS codes for the 5 elements speciﬁed in step 5
‘‘‘‘A.01.01.02.00.00.00”,
‘‘‘‘A.01.02.01.01.00.00”,
‘‘‘‘A.01.02.09.02.01.00”,
‘‘‘‘D.01.01.01.00.00.00”,
‘‘‘‘A.01.01.07.00.00.00”
FROM <local database view name at clinic B>
WHERE
‘‘A.01.01.01.03.00.00” = 1 //meaning gender = female
AND ( //deﬁnition of Atherosclerotic_Ischemic_Stroke
( //deﬁnition of Ischemic_Stroke,
//involving 11 CDS-level constraints, NOT DETAILED HERE
. . .
)
AND (
//deﬁnition of Atherosclerotic_Disease,
//involving a single phenotype-level mapping
Atherosclerotic_Disease = ‘yes’
)
)
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A.1. Exploiting the Reference Ontology in a concrete test case
This section exempliﬁes the use of the NEUROWEB Reference
Ontology for queries as well as the interactions between the user
and the system interface. We will focus on the top phenotype Ath-
erosclerotic_Ischemic_Stroke, which is deﬁned as the intersection of
Ischemic_Stroke and Atherosclerotic_Disease. Speciﬁcally, the pres-
ence of Atherosclerotic_Disease in a patient is deﬁned in the Refer-
ence Ontology as a disjunction of ﬁve CDS-level constraints (CDS
alphanumeric codes are displayed between parentheses).
 Presence of myocardial infarction = yes, within 4 weeks
(A.01.02.02.10.01.00 = 2).
 Presence of angina pectoris = yes
(A.01.02.02.11.01.00 = 2). Presence of family stroke/TIA = yes
(A.01.02.02.09.01.00 = 2)
 Presence of arterial hypertension = yes
(A.01.02.02.05.01.00 = 2).
 Presence of hypercholesterolemia = yes
(A.01.02.02.07.01.00 = 2).
The structure of this phenotype is shown in the lower right part
of Fig. A.2. We omit the deﬁnition of Ischemic Stroke only for
simplicity.
Now we show a typical use of the NEUROWEB system, focusing
on how the reference ontology is exploited for clinical, genomic,
and literature searches.
(1) Deﬁne the mapping. Suppose that two NEUROWEB clinics
(clinic A and clinic B) compile the NEUROWEB-to-Local map-
ping for a subset of the CDS elements. Clinic A has full CDS
mapping, whereas clinic B can support mapping only at the
phenotype level forAtherosclerotic disease. The list of supported
CDS elements andphenotypes is sent and stored in the central
database. The clinics also set up their local web services.
(2) Deﬁne the goal. A NEUROWEB user, with read access granted
to the databases of clinic A and B, intends to study how ath-
erosclerotic ischemic stroke in women might be associated
with genetic polymorphisms.
(3) Select a data source. The user enters the NEUROWEB portal
and selects clinic A and clinic B as data sources. If we con-
sider the whole query as SELECT data elements of interest
FROM clinical DBs of interest WHERE patient ﬁlter condition,
then this step speciﬁes the FROM part (Fig. A.1).
(4) Specify a phenotype. The usermoves to the next tab of theGUI
to specify a phenotype. She selects the phenotype Atheroscle-
rotic ischemic stroke. The tree structure, with the CDS elements
as leaf nodes, appears in the right pane (see Fig. A.2) The tree
shows the logical relations (AND/OR) of its branches aswell as
the requireddatavaluesat theCDSelements.Note that the top
phenotype Atherosclerotic_Ischemic_Stroke is deﬁned as
Ischemic_Stroke AND Atherosclerotic_Disease. Fig. A.2 does not
show the structure of the low phenotype Ischemic_Stroke.The
user can browse and modify the phenotype tree at any level,
for example, she can change the value of CDS elementPresence
of angina pectoris from ‘‘yes” to ‘‘no”. The GUI supports any
combination of existing phenotypes and CDS elements to
form a new phenotype, which the user can save as her own
phenotype for future use. Now she wants to specify female
patients, so she adds the CDS element ‘‘Gender” and sets its
value to ‘‘Female”, then connects it to the phenotype treewith
an AND relation. This action is shown in Fig. A.2.TheGUI reads
the ReferenceOntology to display the tree. The user-compiled
phenotype will later be the source of the WHERE part of the
query.
(5) Select the dataset elements. The user selects on the next tab
the CDS elements or phenotypes that she wants to view for
the patients matching the user-deﬁned phenotype. This list
will be the SELECT part of the query. If this list contains
an item that is unsupported for a certain clinic, the returned
values will be null. Suppose that the user selects:
 Date of birth (CDS code A.01.01.02.00.00.00).
 Date of admission (CDS code A.01.02.01.01.00.00).
 Discharge status (CDS code A.01.02.09.02.01.00).
 Time between onset and ﬁrst scan (CDS code
D.01.01.01.00.00.00).
 Marital status (CDS code A.01.01.07.00.00.00).(6) Running the query. The user can set some additional param-
eters and then execute the query. The phenotype is sent to
the Phenotype Converter that, using the mapping informa-
482 G. Colombo et al. / Journal of Biomedical Informatics 43 (2010) 469–484tion, produces two different WHERE parts for the clinics A and
B.
 For clinic A, the query will contain the AND/OR combina-
tion of the 16 CDS-level constraints that make up the
phenotype, plus the constraint on gender. See Table A.1.
 For clinic B, the query will contain Atherosclerotic dis-
ease = ‘yes’ instead of the 5 CDS-level constraints that
deﬁne Atherosclerotic disease in the Reference Ontology.
This clause is combined with several other CDS con-
straints like Presence of angina pectoris = ‘no’ etc., coming
from the other parts of the user-deﬁned phenotype tree.
See Table A.2The two queries, with the same SELECT parts, are sent to the
clinical web services declared in the FROM part, and the matching
records are returned (Fig. A.3).Fig. A.3. The patient set returned as a response, alongside aggregate
Fig. A.4. Semantic Que(7) Analyze the result set. The user can browse aggregate and
detail information on the patients in tabular form. She can
run data mining methods like decision tree to select the
dominant variables of the SELECT part, with respect to any
variable chosen as class label. She can also save the complete
query as well as the returned patient set to ensure consis-
tency with future queries in longitudinal studies.
(8) Run a semantic query. The goal here is to ﬁnd publications
that link the user-deﬁned phenotype to a chromosome.
When started, the Semantic Engine searches a cached copy
of public resources like MedLine to ﬁnd publications rele-
vant to the phenotype speciﬁed by the user. The engine
extracts search terms from the phenotype tree, also allowing
the user to edit them. Then it runs the search, using the Ref-
erence Ontology also to rewrite the term list in case of tood data (upper part) and individual patient records (lower part).
ry deﬁnition GUI.
G. Colombo et al. / Journal of Biomedical Informatics 43 (2010) 469–484 483few or too many hits. The user views the ranked and high-
lighted abstracts, and may reﬁne the original phenotype
accordingly (see Fig. A.4).
(9) Run a genomic query. Suppose the locus 9p21 was suggested
by the relevant publications in the previous step. Now, using
the Genomic Engine, the user can search public genomic dat-
abases to ﬁnd out which SNPs are associated to this locus,
and then check which of these her patients in the returned
record set actually have, thus verifying the original hypoth-
esis. This concludes the phenotype–genotype association
study.
The above example demonstrated a phenotype–genotype study.
The NEUROWEB tools, however, can be used for other purposes
like verifying a suggested treatment in the partners’ databases
for a certain phenotype or a single patient.References
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